Jamsranjav, Enkhtsetseg
Loading...
Товч нэр
Jamsranjav, Enkhtsetseg
Бүтэн нэр
Jamsranjav Enkhtsetseg
Латин нэр
Jamsranjav Enkhtsetseg
Албан тушаал
Судлаач
ORCID
3 results
Now showing 1 - 3 of 3
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Pregnancy Outcome in Women with Gestational Diabetes Mellitus: Age and Pre-pregnancy BMI-Matched Prospective Cohort Study in Ulaanbaatar of Mongolia(Mongolian National University of Medical Sciences, 2024-06-30); ; ;Chuluunbileg BatboldObjective: This study aimed to assess maternal outcomes in women with Gestational Diabetes Mellitus. Method: A multicenter, age, and pre-pregnancy body mass index-matched prospective cohort study was conducted in five maternity hospitals across Ulaanbaatar, Mongolia, between February and April 2022. All participants (24-28 weeks pregnant) underwent an oral glucose tolerance test (OGTT; 75 g, oral glucose, capillary), and the results were considered as GDM (ADA, 2022). The GDM and non-GDM groups were followed from pregnancy to delivery. Maternal and neonatal delivery outcome data were extracted from the clinical records of five maternity hospitals. Results: The mean age and pre-pregnancy BMI were 35.05±3.8 years and 26.21±3.7 kg/m2, respectively. According to the univariate analysis, women with gestational diabetes had higher rates of pregnancy-induced hypertension, cesarean delivery, and labor induction than the non-GDM group. On the multivariate analysis, the risk of undergoing cesarean delivery and developing pregnancy-induced hypertension were 2.8 (aOR=2.83 CI=1.07-7.47) and 6.9 (aOR=6.91 CI=1.35-35.23) times higher, respectively, in the case group compared to the non-GDM group. Conclusion: Women with GDM had more complications during pregnancy and delivery than those without. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Invasive Hemodynamic Monitoring and Arterial Blood Gas Exchange During Spinal vs General Anesthesia for Cesarean Delivery in Mongolian Parturient(Mongolian National University of Medical Sciences, 2024-12-12); ; ; Objective: This study investigated the accuracy and precision of continuous, invasive blood pressure obtained using the arterial line system in patients undergoing cesarean section with spinal and general anesthesia. Methods: A total of 150 parturient women who underwent C-sections from July 1, 2021, to Dec 30, 2023, were divided into two groups: the GA (general anesthesia) group (n=50) and the SA (spinal anesthesia) group (n=100). In this prospective observational study, we measured and compared the changes in hemodynamic fluctuation and arterial blood gas deviations under C-section with either spinal or general anesthesia. Results: One hundred fifty patients were recruited for the study after exclusions, and data were analyzed for 150 patients. There were no significant differences in the time from anesthesia to incision, the operation duration, infused crystalloid volume, blood loss, and urine output. The most frequent complications were surgery hypotension, tachycardia, nausea, and headache in the SA group, and tachycardia, hypertension, in the GA group These complications may cause SA’s impact on the sympathetic nerves, resulting in dilated blood vessels and reflex tachycardia. Conclusion: It has been suggested that the choice of anesthesia technique has a significant impact on hemodynamic stability during cesarean section. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Outcome of Uterine Artery Embolization in the Treatment of Uterine Leiomyomas in Mongolia(Mongolian National University of Medical Sciences, 2018-03-25) ;Rentsenkhuu, Uranchimeg ;Rentsenkhuu, Ganbaatar ;Lkhagva, Bayarmaa ;Tsevegmid, ErdembilegObjective: To evaluate and determine treatment efficacy of uterine artery embolization versus uterine myomectomy in treating uterine leiomyomas. Methods: In 2010-2013, 94 women between the ages of 23-50 years were recruited in the study. They were divided into 2 treatment groups: uterine artery embolization and myomectomy (control) group and were followed up for two consecutive years. Results: After uterine artery embolization, the volume of leiomyomas decreased 56%-91% (p<0.05). Menorrhagia in the uterine artery embolization versus myomectomy group was 95.2% and 92.8% (p>0.05), anemia 87.5% and 85.7% (p>0.05), pain subsided 72.2% versus 86.8% and "bulk" symptoms 87.5% versus 100% respectively (p>0.05). Overall health-related quality of life score +27.6 versus +17.1 and SS score -34.0 versus -32.8, patient satisfaction 89.4% versus 72.3% (p=0.001). Re-growth after uterine artery embolization 2.1% versus myomectomy 23.4% (p=0.0001), Post-treatment conception 25.5% versus 31.9% and cesarean delivery rate 88.9% versus 90% respectively (p>0.05). Duration of the procedure 38.9±4.8 minutes versus 54.0±26.3 minutes (p=0.0001), length of hospital stay 2.4±0.9 days versus 6.9±2.3 days (p=0.0001), days to recovery 10.6±3.0 versus 26.2±17.9 (p=0.0001). Conclusion: Uterine artery embolization treatment effectively decreases the size of leiomyomas (p=0.015), it particularly improves menorrhagia. The quality of life and patient satisfaction scores after uterine artery embolization are better (p=0.001). There was no statistically significant difference with regard to conception rate or the need for cesarean delivery (p>0.05).
